Disclaimer: I’m participating in the Break Up with Your Makeup program sponsored by Galderma Laboratories, L.P. the maker of Oracea® (doxycycline) 40 mg* Capsules, Soolantra® (ivermectin) Cream, 1% and Mirvaso® (brimonidine) Gel, 0.33%**.
Beautiful skin means more than that flawless, imperfection-free look that so many commercials push these days. In my mind, beautiful skin means the skin you’re in. Your skin is beautiful because it’s YOURS! Instead of covering up the imperfections on your face like you’re a pariah, address them, and be proud that your skin is yours.
Beautiful Skin and Galderma
Galderma Laboratories, L.P. wants to help you embrace your skin and be more comfortable in it. The Break Up with Your Makeup campaign was created by Galderma to motivate women to stop hiding skin issues with makeup and start treating those issues instead. Rather than covering up rosacea with a ton of makeup – which only serves to make rosacea worse – embrace your own beautiful skin. Treat your skin issue, don’t hide it and make it worse. Your skin is part of you, and it’s beautiful.
I had a friend with moderate rosacea. She was so self-conscious about it. Rather than addressing it, she covered it up with makeup for years. Of course, all of that makeup on her face every day only made her rosacea worse. Over the years, it became harder and harder for her to cover it up, and at a certain point, you could see that something was going on under there. The point is that instead of embracing her skin, she hid it, and it only made things worse.
That’s the whole point of the Break Up with Your Makeup campaign. Galderma wants women everywhere to recognize that beautiful skin means the skin we’re in. Not the skin that we’re “supposed to have”. Galderma wants to help women help themselves by promoting a new thought process. Instead of covering up rosacea, treat it.
Galderma Rosacea Products Treat the Symptoms of Rosacea
- SOOLANTRA® (ivermectin) Cream, 1% is approved by the FDA for once-daily, topical treatment of inflammatory lesions, or bumps and pimples, of rosacea.
- ORACEA® (doxycycline) 40 mg* Capsules are indicated for the treatment of only inflammatory lesions, or bumps and pimples, of rosacea.
- MIRVASO® (brimonidine) topical gel, 0.33%** is indicated for the topical treatment of persistent facial erythema (chronic redness) of rosacea in adults.
Your Beautiful Skin Isn’t Something to Be Ashamed Of
I clearly recall telling my friend over and over again that her rosacea was nothing to be ashamed of. That it didn’t make her who she was. It fell on deaf ears, but I get it. When you suffer from something so visible, it can be difficult to come to terms with it. The thing is, we need to remember that our skin is part of us, and that makes it beautiful.
So if you suffer from rosacea, Break Up with Your Makeup, and make the most of your beautiful skin. Some Galderma products may be able to help you reduce the appearance of rosacea rather than just covering it up, and that is a beautiful thing!
Important Safety Information for Oracea® Capsules
Indication: ORACEA® (doxycycline, USP) 40 mg* Capsules are indicated for the treatment of only
inflammatory lesions (papules and pustules) of rosacea in adult patients. ORACEA Capsules do not lessen the facial redness caused by rosacea. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in patients treated with ORACEA Capsules were nasopharyngitis, sinusitis, diarrhea, hypertension and aspartate aminotransferase increase. Warnings/Precautions: ORACEA Capsules should not be used to treat or prevent infections. ORACEA Capsules should not be taken by patients who have a known hypersensitivity to doxycycline or other tetracyclines. ORACEA Capsules should not be taken during pregnancy, by nursing mothers, or during tooth development (up to the age of 8 years). Although photosensitivity was not observed in clinical trials, ORACEA Capsules patients should minimize or avoid exposure to natural or artificial sunlight. The efficacy of ORACEA Capsules treatment beyond 16 weeks and safety beyond 9 months have not been established.
*30 mg immediate release & 10 mg delayed release beads
Important Safety Information for Soolantra® Cream
Indication: SOOLANTRA® (ivermectin) Cream, 1%, is indicated for the treatment of inflammatory lesions of rosacea. Not for oral, ophthalmic or intravaginal use. Adverse Events: In clinical trials with SOOLANTRA® Cream, the most common adverse reactions (incidence ≤1%) included skin burning sensation and skin irritation.
Important Safety Information for Mirvaso® Gel
Indication: Mirvaso® (brimonidine) topical gel, 0.33%** is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.
**Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
All trademarks are the property of their respective owners.